Evidence map›Paper›PMID 31749800›Full record

ArticleFrontiers in immunology2019

Maturation of Gut Microbiota and Circulating Regulatory T Cells and Development of IgE Sensitization in Early Life.

Terhi Ruohtula, Marcus C de Goffau, Janne K Nieminen, Jarno Honkanen, Heli Siljander, Anu-Maaria Hämäläinen, Aleksandr Peet, Vallo Tillmann, Jorma Ilonen, Onni Niemelä and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04662619 (A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Nutritional Intervention Study to Examine the Clinical and Immunological Effects of a Probiotic Food Supplement Containing B. Infantis), which is not on this map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04662619 nacompletednot on this mapstarted 2020, after this paper: background citation

A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled, Two-Arm, Parallel-Group, Nutritional Intervention Study to Examine the Clinical and Immunological Effects of a Probiotic Food Supplement Containing B. Infantis (EVC001) in Healthy Breastfed Infants at Risk of Developing Atopic Dermatitis

TypeinterventionalSponsorJohnson & Johnson Consumer Inc. (J&JCI)Ran2020 to 2024Enrolled273ConditionsHealthyArmsB. infantis, Lactose Placebo
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Article
  9. Regulatory T-Cells During Pregnancy Relate to Women's Own Childhood History of Microbial Exposure.American journal of human biology : the official journal of the Human Biology Council · 2025
    Article
  10. Review
  11. Article
  12. Nutrients · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Household size, T regulatory cell development, and early allergic disease: a birth cohort study.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Article
  19. Review
  20. Microbiome assembly in The Gambia.Nature microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 3 countries.

Terhi RuohtulaClinicum, University of Helsinki, Helsinki, Finland.
Marcus C de GoffauDepartment of Medical Microbiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Janne K NieminenClinicum, University of Helsinki, Helsinki, Finland.
Jarno HonkanenClinicum, University of Helsinki, Helsinki, Finland.
Heli SiljanderChildren's Hospital, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
Anu-Maaria HämäläinenDepartment of Pediatrics, Jorvi Hospital, Helsinki University Hospital, Espoo, Finland.
Aleksandr PeetImmunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.
Vallo TillmannDepartment of Pediatrics, Tartu University Hospital, University of Tartu, Tartu, Estonia.
Jorma IlonenImmunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.
Onni NiemeläDepartment of Laboratory Medicine and Medical Research Unit, Seinäjoki Central Hospital and University of Tampere, Seinäjoki, Finland.
Gjalt W WellingDepartment of Medical Microbiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Mikael KnipClinicum, University of Helsinki, Helsinki, Finland.
Hermie J HarmsenDepartment of Medical Microbiology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands.
Outi VaaralaClinicum, University of Helsinki, Helsinki, Finland.
University of Helsinki · FIHelsinki University Hospital · FIUniversity Medical Center Groningen · NLUniversity of Turku · FITampere University · FITartu University Hospital · EEUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies suggest that the cross-talk between the gut microbiota and human immune system during the first year of life is an important regulator of the later development of atopic diseases. We explored the changes in the gut microbiota, blood regulatory T cells, and atopic sensitization in a birth-cohort of Estonian and Finnish children followed from 3 to 36 months of age. We describe here an infant Treg phenotype characterized by high Treg frequency, the maturation of Treg population characterized by a decrease in their frequency accompanied with an increase in the highly activated Treg cells. These changes in Treg population associated first with the relative abundance of Bifidobacterium longum followed by increasing colonization with butyrate producing bacteria. High bifidobacterial abundance in the neonatal microbiota appeared to be protective, while colonization with

Indexed as

AgingBacteriaBifidobacterium longumChild, PreschoolCohort StudiesFemaleFinlandGastrointestinal MicrobiomeHumansHypersensitivityImmunoglobulin EInfantLymphopoiesisMaleT-Lymphocytes, RegulatoryImmunoglobulin Eatopic diseasesbifidobacteriagut microbiomeIgEregulatory T-cells

Identifiers

PMID31749800
PMCPMC6842923
OpenAlexW2981822064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.